DOI : https://doi.org/10.18517/ijaseit.13.6.19110

In Silico Docking to Explore the Coronavirus-2 ACE2 Inhibitor Potential in Brown Seaweed Padina sp. from Morotai Island, North Maluku, Indonesia

Sundari (1), Khadijah (2), Aras Syazili (3), Lia Hapsari (4), Abdu Mas'ud (5)
(1) Biology Education Department, Faculty of Teacher Training and Education, University of Khairun, Ternate, North Maluku, Indonesia
(2) Chemistry Education Department, Faculty of Teacher Training and Education, University of Khairun, Ternate, North Maluku, Indonesia
(3) Aquaculture Department, Faculty of Fisheries and Marine Sciences, University of Khairun, Ternate, North Maluku, Indonesia
(4) Research Center for Plant Conservation, Botanic Gardens and Forestry, National Research and Innovation Agency, Cibinong, Indonesia
(5) Biology Education Department, Faculty of Teacher Training and Education, University of Khairun, Ternate, North Maluku, Indonesia
Fulltext View | Download
How to cite (IJASEIT) :
[1]
Sundari, Khadijah, A. Syazili, L. Hapsari, and A. Mas’ud, “In Silico Docking to Explore the Coronavirus-2 ACE2 Inhibitor Potential in Brown Seaweed Padina sp. from Morotai Island, North Maluku, Indonesia”, Int. J. Adv. Sci. Eng. Inf. Technol., vol. 13, no. 6, pp. 2081–2087, Dec. 2023.
Citation Format :
Efforts to explore new sources of antivirals for coronavirus-2 from abundant marine natural materials are highly encouraged. The study aimed to explore the potential compounds of brown seaweed Padina sp. from Morotai Island extracted using three solvents, i.e., n-hexane, ethyl acetate, and acetone, as an antiviral against coronavirus-2 through an entry inhibitor mechanism using bioinformatics tools. The target protein was Angiotensin-Converting Enzyme-related carboxypeptidase (ACE2) receptor. Protein structure was downloaded from PDB and prepared using Chimera. The interaction of compounds to ACE2 was predicted using AutoDock4 and AutoDockTools. MLN-4760 was used as a standard compound. Results showed that 15 selected compounds were potential as ACE2 inhibitors, resulting in negative binding energies, low inhibition constant, and varying binding modes. The conformation structure of all compounds was occupied on the ACE-2 active site. Four compounds were highly potential as ACE2 inhibitors with binding energy lower than a standard compound, comprised of Neophytadiene (diterpene); 6,9,12,15-Docosatetraenoic acid, methyl ester (fatty acid); N-Dimethylaminomethyl-tert-butyl-isopropylphosphine (alkaloid) and 8,11-Octadecadienoic acid, methyl ester (fatty acid). Ethyl acetate and acetone are suggested to be used as solvents for the extraction to produce compounds as ACE2 inhibitors, but ethyl acetate was found to be the most effective. Brown seaweed of Padina sp. is recommended to be developed as a pharmaceutical and nutraceutical preparation for COVID-19. Further in vivo and in vitro studies are suggested to confirm this study's results and provide stronger evidence.

M. Kandeel, J. Kim, M. Fayez, Y. Kitade, and H. Kwon, "Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease," PeerJ, vol. 10, no. e12929, pp. 1-20, 2022. doi: 10.7717/peerj.12929.

M. A. Rahman, S. Cronmiller, Y. Shanjana, and M. Bhuiyam, "The WHO announced COVID-19 is no longer a global public health emergency amid the spreading of Arcturus variant: A correspondence evaluating this decision," Int. J. Surg., vol. 25, no. 37222689, pp. 1-7, 2023. doi: 10.1097/JS9.0000000000000522.

A. Rauf, U. Rashid, A. A. Khalil, S. A. Khan, and S. Anwar, "Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae ," South African J. Bot., vol. 143, pp. 428-434, 2020. doi: 10.1016/j.sajb.2021.06.033.

M. Drobysh et al., "Biosensors for the determination of SARS-CoV-2 virus and diagnosis of COVID-19 infection," Int. J. Mol. Sci., vol. 23, no. 666, pp. 1-25, 2022. doi: 10.3390/ijms23020666.

R. Garcí­a et al., "Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset," Comput. Biol. Med., vol. 133, no. 104364, pp. 1-12, 2021. doi: 10.1016/j.compbiomed.2021.104364.

S. Gao, T. Huang, L. Song, and S. Xu, "Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors," Acta Pharm. Sin. B, vol. 12, no. 2, pp. 581-599, 2022. doi: 10.1016/j.apsb.2021.08.027.

A. G. Harrison, T. Lin, and P. Wang, "Mechanisms of SARS-CoV-2 transmission and pathogenesis," Trends Immunol., vol. 41, no. 12, pp. 1100-1115, 2020. doi: 10.1016/j.it.2020.10.004.

B. Hu, H. Guo, P. Zhou, and Z.-L. Shi, "Characteristics of SARS-CoV-2 and COVID-19," Nat. Rev. Microbiol., vol. 19, pp. 141-154, 2019. doi: 10.1038/s41579-020-00459-7.

D. J. Newman and G. M. Cragg, "Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019," J. Nat. Prod., vol. 83, pp. 770-803, 2020. doi: 10.1021/acs.jnatprod.9b01285.

A. Al-Harrasi, T. Behl, T. Upadhyay, S. Chigurupati, and S. Bhatt, "Targeting natural products against SARS-CoV-2," Environ. Sci. Pollut. Res., vol. 29, pp. 42404-42432, 2022. doi: 10.1007/s11356-022-19770-2.

Y. Kumar, A. Tarafdar, and P. C. Badgujar, "Seaweed as a source of natural anti-oxidants”¯: Therapeutic activity and food applications," J. Food Qual., vol. 5753391, pp. 1-17, 2021. doi: 10.1155/2021/5753391.

H. Padmi et al., "Macroalgae bioactive compounds for the potential antiviral of SARS-CoV-2”¯: An in silico study," J. Pure Appl. Microbiol., vol. 16, no. 2, pp. 1018-1027, 2022. doi: 10.22207/JPAM.16.2.26.

S. Lomartire and A. M. M. Gonçalves, "An overview of potential seaweed-derived bioactive compounds for pharmaceutical applications," vol. 20, no. 141, pp. 1–32, 2022. doi: 10.3390/md20020141.

N. R. Fitri, I. F. Nuryanti, D. Mutamimah, and N. Adharani, "Phytochemicals and anti-oxidant of seaweed tea," Int. J. Mar. Eng. Innov. Res., vol. 6, no. 4, pp. 255-258, 2021. doi: 10.12962/j25481479.v6i4.11636.

J. R. Hidayati, M. S. Bahry, I. Karlina, and E. Yudiati, "Anti-oxidant activity and bioactive compounds of tropical brown algae Padina sp. from Bintan Island, Indonesia," J. Kelaut. Trop., vol. 25, no. 3, pp. 309-319, 2022. doi: 10.14710/jkt.v25i3.15562.

A. Kumar et al., "Algal metabolites can be an immune booster against COVID-19 pandemic," Anti-oxidants, vol. 11, no. 452, pp. 1-17, 2022. doi: 10.3390/antiox11030452.

H. Achmad, Huldani, A. B. Carmelita, Fauziah, N. Hidayah, and D. Bokov, "Anti-oxidant and antiviral potential of brown algae (Phaeophyceae )," Int. J. Pharm. Res., vol. 12, no. 3, pp. 2117-2125, 2020. doi: 10.31838/ijpr/2020.12.03.292.

Khadijah, N. H. Soekamto, Firdaus, and Y. M. Syah, "Total content of phenol and anti-oxidant activity from crude extract methanol of brown algae (Padina sp. ) collected from Kayoa Island, North Maluku," J. Phys. Conf. Ser., vol. 1899, no. 012034, pp. 1-10, 2021. doi:10.1088/1742-6596/1899/1/012034.

Sundari, "The potential of Padina sp. brown seaweed from Morotai, Ternate and Kayoa waters as an ACE2 inhibitor to prevent the spread of the SARSCoV-2," University of Khairun, Ternate, North Maluku, Indonesia, 2020.

Y. Fu, J. Zhao, and Z. Chen, "Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation”¯: A case of oligopeptide binding protein," Comput. Math. Methods Med., vol. 3502514, pp. 1-14, 2018. doi: 10.1155/2018/3502514.

A. Khayrani, R. Irdiani, R. Aditama, D. Kartika, and K. Lischer, "Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study," J. King Saud Univ. - Sci., vol. 33, no. 101297, pp. 1-13, 2020. doi: 10.1016/j.jksus.2020.101297.

E. F. Pettersen et al., "UCSF Chimera — A visualization system for exploratory research and analysis," J. Comput. Chem., vol. 25, no. 23, pp. 1605-1612, 2004. doi: 10.1002/jcc.20084.

B. Nami et al., "The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation," J. Hypertension, vol. 39, pp. 1705-1716, 2021. doi: 10.1097/HJH.0000000000002829.

L. Wang et al., "Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein," Acta Pharmacol. Sin., vol. 43, pp. 788-796, 2022. doi: 10.1038/s41401-021-00735-z.

G. M. Morris et al., "Software news and updates AutoDock4 and AutoDockTools4”¯: Automated docking with selective receptor flexibility," J. Comput. Chem., vol. 30, no. 16, pp. 2785-2791, 2009. doi: 10.1002/jcc.21256.

G. M. Morris et al., "Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function," J. Comput. Chem., vol. 19, no. 14, pp. 1639-1662, 1998. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.

R. Huey, G. M. Morris, A. J. Olson, and D. S. Goodsell, "Software news and update a semiempirical free energy force field with charge-based desolvation," J. Comput. Chem., vol. 28, no. 6, pp. 1145-1152, 2007. doi: 10.1002/jcc.20634.

L. G. Ferreira, R. N. Santos, G. Oliva, and A. D. Andricopulo, "Molecular docking andstructure-based drug design strategies," Molecules, vol. 20, pp. 13384-13421, 2015. doi: 10.3390/molecules200713384.

A. M. Darwesh, W. Bassiouni, D. K. Sosnowski, and J. M. Seubert, "Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?," Pharmacol. Ther. J., vol. 219, no. 107703, pp. 1-27, 2020. doi: 10.1016/j.pharmthera.2020.107703.

A. Vivar-sierra et al., "In silico study of polyunsaturated fatty acids as potential SARS-CoV-2 spike protein closed conformation stabilizers”¯:," Molecules, vol. 26, no. 711, pp. 1-13, 2021. doi: 10.3390/molecules26030711.

A. Goc, A. Niedzwiecki, and M. Rath, "Polyunsaturated ω ”‘ 3 fatty acids inhibit ACE2”‘controlled SARS”‘CoV”‘2 binding and cellular entry," Sci. Rep., vol. 11, no. 5207, pp. 1-12, 2021. doi: 10.1038/s41598-021-84850-1.

K. J. S. Kumar et al., "Geranium and lemon essential oils and their active compounds downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain in epithelial cells," vol. 2, no. 12, 2019. doi: 10.3390/plants9060770.

C. E. Duru, I. A. Duru, and A. E. Adegboyega, "In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS”‘CoV”‘2 targets," Bull. Natl. Res. Cent., vol. 45, no. 57, pp. 1-13, 2021. doi: 10.1186/s42269-021-00517-x.

E. G. Geromichalou and G. D. Geromichalos, "In silico approach for the evaluation of the potential antiviral constituents oleuropein and oleocanthal on spike therapeutic drug target of SARS-CoV-2," Molecules, vol. 27, no. 7572, pp. 1-55, 2022. doi: 10.3390/molecules27217572.

B. Thuy et al., "Investigation into SARS-CoV”‘2 resistance of compounds in garlic essential oil," ACS Omega, vol. 5, p. 8312−8320, 2020. doi: 10.1021/acsomega.0c00772.

O. A. Pratama, W. Anindito, S. R. I. Tunjung, and B. S. Daryono, "Bioactive compound profile of melon leaf extract (Cucumis melo L . 'Hikapel') infected by downy mildew," Biodiversitas, vol. 20, no. 11, pp. 3448-3453, 2019. doi: 10.13057/biodiv/d201143.

M. B. Majnooni, S. Fakhri, G. Bahrami, M. Naseri, M. H. Farzaei, and J. Echeverr, "Alkaloids as potential phytochemicals against SARS-CoV-2”¯: Approaches to the associated pivotal mechanisms," Evidence-Based Complement. Altern. Med., vol. 6632623, pp. 1-21, 2021. doi: 10.1155/2021/6632623.

P. H. de Matos et al., "Bioactive compounds as potential angiotensin”‘converting enzyme II inhibitors against COVID ”‘ 19”¯: a scoping review," Inflamm. Res., vol. 71, pp. 1489-1500, 2022. doi: 0.1007/s00011-022-01642-7.

H. Nawaz, M. A. Shad, N. Rehman, H. Andaleeb, and N. Ullah, "Effect of solvent polarity on extraction yield and anti-oxidant properties of phytochemicals from bean (Phaseolus vulgaris) seeds," Brazilian J. Pharm. Sci., vol. 56, no. e17129, pp. 1-9, 2015. doi: 10.1590/s2175-97902019000417129.

A. Akbar, N. H. Soekamto, Firdaus, and Bahrun, "Anti-oxidant of n-hexane , ethyl acetate and methanol extracts of Padina sp with DPPH method Anti-oxidant of n-hexane, ethyl acetate and methanol extracts of Padina sp. with DPPH method," IOP Conf. Ser. Earth Environ. Sci., vol. 800, no. 012019, pp. 1-6, 2021. doi: 10.1088/1755-1315/800/1/012019.

P. Garcia-perez et al., "Pigment composition of nine brown algae from the Iberian Northwestern coastline”¯: Influence of the extraction solvent," Mar. Drugs, vol. 20, no. 113, pp. 1-17, 2022. doi: 10.3390/md20020113.

R. K. Saini, P. Prasad, X. Shang, and Y. Keum, "Advances in lipid extraction methods — A review," Int. J. Mol., vol. 22, no. 13645, pp. 1-19, 2021. doi: 10.3390/ijms222413643.

C. M. Galanakis, "Functionality of food components and emerging technologies," Foods, vol. 10, no. 128, pp. 1-26, 2021. doi: 10.3390/foods10010128.

R. B. S. S. Nogueira et al., "Brown algae Padina sanctae-crucis Bí¸rgesen”¯: A potential nutraceutical," Mar. Drugs, vol. 15, no. 251, pp. 1-15, 2017. doi: 10.3390/md15100251.

P. Weill, C. Plissonneau, P. Legrand, and V. Rioux, "May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?," Biochimie, vol. 179, pp. 275-280, 2020. doi: 10.1016/j.biochi.2020.09.003.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).